Cardiovascular Devices Companies

Abbott acquires Tendyne Holdings: In December 2023, medical technology giant Abbott completed the acquisition of Tendyne Holdings, a company specializing in transcatheter tricuspid valve replacement (TTVR) devices. This move strengthens Abbott's presence in the growing TTVR market, expected to reach $4.5 billion by 2028.

Siemens Healthineers partners with Medtronic These two industry titans have collaborated to develop and commercialize a next-generation image-guided therapy platform for cardiovascular procedures. This partnership leverages Siemens' imaging expertise and Medtronic's interventional devices to improve procedural accuracy and outcomes.

Edwards Lifesciences unveils the SAPIEN 3 Ultra Transcatheter Aortic Valve System next-generation TAVR system features a smaller delivery system and enhanced valve design, aiming to improve patient access and outcomes.

Boston Scientific introduces the WATCHMAN FLX Left Atrial Appendage Closure Device innovative device boasts improved flexibility and conformability, designed to better adapt to diverse left atrial anatomies and reduce procedural complications.

List of Cardiovascular Devices Key Companies in the Market

• B Braun Melsungen AG


• Abbott


• Johnson & Johnson Services, Inc.


• Medtronic


• Boston Scientific Corporation


• LivaNova Plc


• Edwards Lifesciences Corporation


• GE Healthcare


• Siemens Healthcare GmbH


• Terumo Cardiovascular Systems Corporation